866-997-4948(US-Canada Toll Free)

Global Respiratory Partnering 2010-2015: Deal trends, players and financials

Published By :

Current Partnering

Published Date : Jun 2015

Category :

Therapeutic Area

No. of Pages : 754 Pages

The Global Respiratory Partnering 2010-2015 report provides an understanding and access to the respiratory partnering deals and agreements entered into by the worlds leading healthcare companies.

Trends in respiratory partnering deals
Disclosed headlines, upfronts, milestones and royalties by stage of development
Respiratory partnering contract documents
Top respiratory deals by value

The Global Respiratory Partnering 2010-2015 report provides an understanding and access to the respiratory partnering deals and agreements entered into by the worlds leading healthcare companies.

The report provides a detailed understanding and analysis of how and why companies enter respiratory partnering deals. The majority of deals are development stage whereby the licensee obtains a right or an option right to license the licensors respiratory technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.

This report provides details of the latest respiratory agreements announced in the healthcare sector.

Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered – contract documents provide this insight where press releases and databases do not.

This report contains a comprehensive listing of all respiratory partnering deals announced since 2010 including financial terms where available including over 400 links to online deal records of actual respiratory partnering deals as disclosed by the deal parties. In addition, where available, records include contract documents as submitted to the Securities Exchange Commission by companies and their partners.

Contract documents provide the answers to numerous questions about a prospective partner’s flexibility on a wide range of important issues, many of which will have a significant impact on each party’s ability to derive value from the deal.

The initial chapters of the report provide an orientation of respiratory dealmaking and its associated business and partnering activities. This chapter provides an overall introduction to the report and what you will learn from it, whilst chapter 2 provides an overview of the trends in respiratory deal making since 2010, categorizing by deal type, industry sector, stage of development and technology type.

A popular section with readers; chapter 3 covers the average financial deal terms for deals signed in the respiratory field with a stage of development announced. Deals are listed and sectioned by average headlines, upfront payments, milestone payments and royalty rates. The median values of these deals are then presented by stage of development at signing.

Numerous tables and figures are weaved within the report to support the findings and illustrate the trends and activities in respiratory partnering and dealmaking since 2010.

Chapter 4 covers the leading respiratory deals that have been announced over the past five years. Deals are listed by headline value. Where the deal has an agreement contract published at the SEC a link provides online access to the contract. Full deal contract documents where available for each deal are indicated by a yes/no symbol. Within this chapter the most active respiratory deal makers are also listed as well as the deal making activities and the number of deals entered into by the big pharma and biotech companies.

Chapter 5 acts as a contracts reference directory chapter providing a full comprehensive and detailed list of the respiratory partnering deals signed and announced since January 2010. This chapter is organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc), and therapy focus. 

In conclusion, this report gives prospective dealmakers a thorough overview of all the deals announced in the respiratory field preparing them with everything they need to know about partnering in the research, development and commercialization of respiratory technologies and products.

A full appendix is provided at the very end of the report which lists all the respiratory deals announced since 2010 categorized by company A-Z, deal type, stage of development, technology and therapy. Where available contract documents are supplied, these documents include additional deal information in comparison to only the brief summary that is provided through a press release. Readers can analyze the contracts fully by reviewing the detailed terms between the parties under which monies and licensing rights are exchanged. The appendix is useful for looking at all the deals signed by one specific company.

Report scope

Global Respiratory Partnering 2010-2015 is intended to provide the reader with an in-depth understanding and access to respiratory trends and structure of deals entered into by leading companies worldwide.

Global Respiratory Partnering 2010-2015 includes:

Trends in respiratory dealmaking in the biopharma industry since 2010
Analysis of respiratory deal structure
Access to headline, upfront, milestone and royalty data
Access to over 400 respiratory deal records
The leading respiratory deals by value since 2010

In Global Respiratory Partnering 2010-2015, the available deals are listed by:

Company A-Z
Headline value
Stage of development at signing
Deal component type
Specific therapy target

Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

The Global Respiratory Partnering 2010-2015 report provides comprehensive access to available deals and contract documents for over 400 respiratory deals. Analyzing actual contract agreements allows assessment of the following:

What are the precise rights granted or optioned?
What is actually granted by the agreement to the partner company?
What exclusivity is granted?
What is the payment structure for the deal?
How are the sales and payments audited?
What is the deal term?
How are the key terms of the agreement defined?
How are IPRs handled and owned?
Who is responsible for commercialization?
Who is responsible for development, supply, and manufacture?
How is confidentiality and publication managed?
How are disputes to be resolved?
Under what conditions can the deal be terminated?
What happens when there is a change of ownership?
What sublicensing and subcontracting provisions have been agreed?
Which boilerplate clauses does the company insist upon?
Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
Which jurisdiction does the company insist upon for agreement law?
Executive Summary
Chapter 1 – Introduction
Chapter 2 – Trends in respiratory dealmaking
2.1. Introduction
2.2. Respiratory partnering over the years
2.3. Respiratory partnering by deal type
2.4. Respiratory partnering by industry sector
2.5. Respiratory partnering by stage of development
2.6. Partnering by respiratory specific technology type
Chapter 3 – Average financial deal terms for respiratory partnering
3.1. Introduction
3.2. Disclosed financials terms for respiratory partnering
3.3 Respiratory partnering headline values
3.4 Respiratory deal upfront payments
3.5 Respiratory deal milestone payments
3.6 Respiratory royalty rates
Chapter 4 – Leading respiratory deals
4.1. Introduction
4.1. Most active in respiratory partnering
4.2. Top respiratory deals by value
4.3. Big pharma respiratory dealmaking activity
4.4. Big biotech respiratory dealmaking activity
Chapter 5 – Respiratory contracts directory
5.1. Introduction
5.2. Respiratory partnering by company A-Z
5.3. Respiratory partnering stage of development
5.4. Respiratory partnering by deal type
5.6. Respiratory partnering by technology type
Appendix 1 – Directory of respiratory deals by company A-Z 2010-2015*
Appendix 2 – Directory of respiratory deals by stage of development 2010-2015
Appendix 3 – Directory of respiratory deals by deal type 2010-2015
Appendix 4 – Directory of respiratory deals by therapy area 2010-2015
Appendix 5 – Respiratory partnering resource center
About Wildwood Ventures
Current Partnering
Current Agreements
Recent report titles from CurrentPartnering
Order Form – Reports
Table of figures
Figure 1: Respiratory partnering since 2010
Figure 2: Respiratory partnering by deal type since 2010
Figure 3: Respiratory partnering by industry sector since 2010
Figure 4: Respiratory partnering by stage of development since 2010
Figure 5: Respiratory partnering by disease type since 2010
Figure 6: Respiratory partnering by specific technology type since 2010
Figure 7: Respiratory deals with a headline value – by stage of development
Figure 8: Respiratory deals with upfront payment values – by stage of development
Figure 9: Respiratory deals with milestone payment – by stage of development
Figure 10: Respiratory deals with royalty rates
Figure 11: Active respiratory dealmaking activity– 2010 to 2015
Figure 12: Top respiratory deals by value since 2010
Figure 13: Big pharma – top 50 – respiratory deals 2010 to 2015
Figure 14: Big pharma respiratory deal frequency – 2010 to 2015
Figure 15: Big biotech – top 50 – respiratory deals 2010 to 2015
Figure 16: Big biotech respiratory deal frequency – 2010 to 2015
Figure 17: Online partnering resources
Figure 18: Forthcoming partnering events

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *